EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rapid Volumetric Bioprinting Coupled with Dynamic Perfusion Enhances Human Hepatic Organoid Toxicity Testing

Yu Tao iD, Paulina Núñez Bernal iD, Núria Ginés Rodriguez, Manon Christel Bouwmeester iD, Tom J G Walraven iD, Dave Wanders, Linda Kock, Nura van Heck, Kerstin Schneeberger-Verjaal iD, Luc J W van der Laan iD, Bart Spee iD

Cells · 27.07.2026 · 15 (15) · 1342

DOI: 10.3390/cells15151342 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 27.07.2026. Verfasst von Yu Tao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Faculty of Veterinary Medicine, Regenerative Medicine Center Utrecht, Utrecht University, 3584 CT Utrecht, The Nethe…. Hauptthemen laut MEDLINE: Organoids, Perfusion, Liver, Bioprinting. Die Arbeit nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation for Dutch Scientific Research Institutes, China Scholarship Council, the Health-Holland Top consortium for Knowledge and Innovation in Life Sciences & Health (TKI-LSH) grant BEACON.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug-induced liver injury (DILI) remains a major cause of acute liver failure and drug withdrawal from the market. Recently developed three-dimensional (3D) hepatic in vitro systems exhibit improved functionality and drug sensitivity compared with conventional two-dimensional cultures. These 3D models range from simple physiologic-like culture systems to advanced bioreactors with dynamic flow to provide sufficient nutrients and consistent drug exposure. However, whether dynamic perfusion improves sensitivity and reproducibility of hepatotoxicity testing remains unclear. Here, we developed a tailor-made perfusion platform to support volumetric bioprinted hepatic constructs for hepatotoxicity testing. The constructs consist of intrahepatic cholangiocyte organoids (ICOs) differentiated towards hepatocyte lineage and embedded in a gelatin methacryloyl bioresin. For toxicity evaluation, the hepatocyte-like ICO constructs were exposed to prolonged subtoxic acetaminophen treatment (10 mM, 7 days). The perfusion system effectively maintained and enhanced hepatocyte differentiation, evidenced by upregulated hepatic markers under perfused conditions compared to static controls. Testing of acetaminophen hepatotoxicity revealed that the perfused constructs displayed elevated cellular injury, with markedly higher liver injury markers relative to controls. Collectively, this study demonstrates the successful application of perfusion-based 3D model culture and highlights its potential as a more physiological platform for hepatotoxicity risk assessment in drug discovery and regenerative medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrganoidsPerfusionLiverBioprintingToxicity TestsHumansAcetaminophenHepatocytesCell Differentiation

Stichwörter der Autor:innen

acetaminophencholangiocytedisease modelingdrug-induced liver injuryhepatic in vitro modelhepatotoxicityorganoidsperfusion systemtissue engineeringvolumetric bioprinting

Substanzen

Acetaminophen

Autor:innen und Institutionen

  • Department of Clinical Sciences, Faculty of Veterinary Medicine, Regenerative Medicine Center Utrecht, Utrecht University, 3584 CT Utrecht, The Netherlands.
  • Department of Orthopaedics, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands.
  • Division of Toxicology, Wageningen University and Research, 6708 WE Wageningen, The Netherlands.
  • LifeTec Group BV, 5611 ZS Eindhoven, The Netherlands.
  • Department of Surgery, Erasmus MC Transplant Institute, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.

ORCID-Profile: Yu Tao, Paulina Núñez Bernal, Manon Christel Bouwmeester, Tom J G Walraven, Kerstin Schneeberger-Verjaal, Luc J W van der Laan, Bart Spee

Förderung

  • Foundation for Dutch Scientific Research Institutes
  • China Scholarship Council
  • the Health-Holland Top consortium for Knowledge and Innovation in Life Sciences & Health (TKI-LSH) grant BEACON
  • the European Union's Horizon Europe research and innovation program grant NEOLIVER bioprinting
  • the Convergence Health Technology Flagship grant "Organ Transplantation" of the Erasmus MC and TU Delft
  • Chinese Scholarship Council
  • Health-Holland Top consortium for Knowledge and Innovation in Life Sciences & Health (TKI-LSH) grant BEACON
  • European Union’s Horizon Europe research and innovation program grant NEOLIVER bioprinting

Zitieren

APA

Tao, Y., Núñez Bernal, P., Ginés Rodriguez, N., Bouwmeester, M. C., Walraven, T. J. G., Wanders, D., Kock, L., Heck, N. V., Schneeberger-Verjaal, K., van der Laan, L. J. W., & Spee, B. (2026). Rapid Volumetric Bioprinting Coupled with Dynamic Perfusion Enhances Human Hepatic Organoid Toxicity Testing. Cells, 15(15), 1342. https://doi.org/10.3390/cells15151342

Vancouver

Tao Y, Núñez Bernal P, Ginés Rodriguez N, Bouwmeester MC, Walraven TJG, Wanders D, et al. Rapid Volumetric Bioprinting Coupled with Dynamic Perfusion Enhances Human Hepatic Organoid Toxicity Testing. Cells. 2026;15(15):1342. doi:10.3390/cells15151342

BibTeX
@article{Tao2026,
  author = {Tao, Yu and Núñez Bernal, Paulina and Ginés Rodriguez, Núria and Bouwmeester, Manon Christel and Walraven, Tom J G and Wanders, Dave and Kock, Linda and Heck, Nura van and Schneeberger-Verjaal, Kerstin and van der Laan, Luc J W and Spee, Bart},
  title = {Rapid Volumetric Bioprinting Coupled with Dynamic Perfusion Enhances Human Hepatic Organoid Toxicity Testing},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {15},
  pages = {1342},
  doi = {10.3390/cells15151342}
}
Kostenlos starten →